Navigation Links
Statistical Bowl - How the '07 Patriots and the '72 Dolphins Match Up

PHOENIX, Jan. 30 /PRNewswire/ -- Sports pundits across the country have been comparing the so-far unbeaten 2007 New England Patriots to the perfect 1972 Dolphins all year. Now, a New York cardiologist is using the scientific statistics used in large-scale medical trials to determine which of the two teams is superior.

Using a format and approach typically reserved for the cardiovascular therapy studies he writes and reviews, Dr. Jonathan Sackner-Bernstein, a Food & Drug Administration advisor and the Chief Medical Officer at Clinilabs, a clinical research organization in New York, compares the 2007 New England Patriots and the 1972 Miami Dolphins.

Sackner-Bernstein was able to draw conclusions by analyzing the two teams' performance relative to their peers in categories that reflect their relative dominance: total offensive and defensive points and yards. Game-by-game performance for the 2007 Patriots and 1972 Dolphins was adjusted to be relative to all of the games played in each respective year, and then those results were compared directly. In statistical terms, the performance statistics were normalized to the median values. A second analysis further adjusted the two for the basis of comparison, by using the opponents' winning percentage to normalize the scores and yardage.

Sackner-Bernstein's data showed a statistical trend in favor of the Patriots as the better offensive team, scoring more than a touchdown more per game than the Dolphins. However, to counteract the offensive prowess of the Patriots, the '72 Dolphins defense gave up 50 percent fewer points than the '07 Patriots, giving the Dolphins a slight edge. The teams both enjoyed greater net yardage than their opponents by almost the same amount ('07 Patriots +123 yards vs. '72 Dolphins +124 yards).

Using the jargon of medical science, none of the differences noted were statistically significant. In the end, the statistical data show that, provided the Patriots win the Super Bowl, there is no evidence of statistical superiority of either team over the other.

"As a lifelong Dolphins fan, I acknowledge that I was really hoping the data would show that the 1972 Dolphins were superior to the 2007 Patriots," said Dr. Sackner-Bernstein. "Unfortunately, this analysis of the data doesn't lie -- the only way for that to happen now is for the Giants to give the Patriots a notch in the loss column."

Dr. Sackner-Bernstein continued, "It is difficult to make a direct comparison between the two teams beyond the statistics that were analyzed. Players these days are not only bigger, stronger and faster, but there have been changes in the rules for blocking and pass defense that make direct comparisons between the two teams arbitrary."

The full statistical analysis of the '07 Patriots and '72 Dolphins is available to read and includes further insight into parameters, omitted statistics and additional notes of interest. As a cardiologist, Dr. Sackner-Bernstein has made his analysis available on a Web site for cardiovascular health care professionals,, at

About Dr. Sackner-Bernstein

Jonathan D. Sackner-Bernstein, M.D., F.A.C.C. is Chief Medical Officer of Clinical Research at Clinilabs (, a clinical research organization focusing on central nervous system and cardiovascular therapeutics as well as therapies in early clinical development.

Dr. Sackner-Bernstein is an internationally recognized leader in the field of cardiology research. He is particularly known for his expertise in drug safety, which has impacted the design of clinical trials utilizing devices and pharmacologic therapies. Dr. Sackner-Bernstein serves as an advisor to the U.S. Food and Drug Administration's Cardiovascular and Renal Drug Advisory Committee and as an ad-hoc member of its advisory committee. Recently, Sackner-Bernstein was appointed a member of the Medical Devices Dispute Resolution Committee in FDA's Center for Devices and Radiologic Health. He also serves as a regulatory consultant for several firms to help them navigate study design and therapeutic safety for Phase I through Phase IV studies. Dr. Sackner-Bernstein is an active lecturer and visiting professor at leading medical centers around the country.

Media Contacts:

Jonathan Sackner-Bernstein, M.D.

For interviews, please contact:

David Berry, MCS Public Relations

W: (800) 477-9626 x22

C: (908) 872-3777

SOURCE MCS Public Relations
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack
2. Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study
3. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
4. Gleaners Community Food Bank Board Members Match Donations December 19, 2007
5. Marianjoy Rehabilitation Hospital Therapeutic Golf Program Receives a $20,000 Matching Grant From the USGA
6. S3 Matching Technologies Aids in Reducing Risk to Texas Medicaid System
7. Many prostate cancer patients receive improper or mismatched therapies
8. Mismatched prostate cancer treatment more common than expected
9. BCP Veterinary Pharmacy Helps Cure Diabetic Cats with BCP PZI(R), the Closest Match to Feline Insulin Available
10. Neurotechnologija Releases Smartcard Face-Match Add-on for the Implementation of Biometric Face-on-Smartcard Verification Systems
11. Gene Tests Match Up Lung Tumors, Best Treatment
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... transport experience for the millions of people who require these medical transport services ... industry through the use of technology. Now, SmartEMS has put forth an industry-changing ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer ... they remain in the eye of the beholder, according to experts who offered insights ... American Journal of Managed Care. For the full issue, click here . , ...
(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... ... 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop ... The fitness app plans to fix the two major problems leading the fitness industry today:, ... all type program , They don’t eliminate all the reasons people quit their ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology: